Cerenome is trading at $1.91, down -5.45%, with no company-specific announcement identified to explain the September 29 decline.
- Cerenome had announced a September 30 business update call and a Blue Cross Blue Shield of Michigan coverage agreement; neither clearly explains the drop.
- Healthcare is down 1.33% amid broader market weakness, providing sector context but not establishing the cause of Cerenome’s larger decline.
- No reliable volume or activity data was found.